288 related articles for article (PubMed ID: 27588396)
21. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
22. Medullary thyroid carcinoma: management of lymph node metastases.
Moley JF
J Natl Compr Canc Netw; 2010 May; 8(5):549-56. PubMed ID: 20495084
[TBL] [Abstract][Full Text] [Related]
23. Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems.
Jin ML; Gong Y; Pei YC; Ji P; Hu X; Shao ZM
Breast; 2020 Feb; 49():93-100. PubMed ID: 31783315
[TBL] [Abstract][Full Text] [Related]
24. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study.
Shi X; Huang NS; Lei BW; Song KH; Shi RL; Wei WJ; Hu WP; Dong F; Wang Y; Wang YL; Ji QH
Ann Surg Oncol; 2018 Aug; 25(8):2316-2322. PubMed ID: 29845406
[TBL] [Abstract][Full Text] [Related]
25. Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancer.
Machens A; Lorenz K; Weber F; Dralle H
Head Neck; 2022 Dec; 44(12):2717-2726. PubMed ID: 36065717
[TBL] [Abstract][Full Text] [Related]
26. Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.
Zhang JW; Chu YM; Lan ZM; Tang XL; Chen YT; Wang CF; Che X
World J Gastroenterol; 2015 Apr; 21(14):4255-60. PubMed ID: 25892876
[TBL] [Abstract][Full Text] [Related]
27. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients.
Kazaure HS; Roman SA; Sosa JA
Cancer; 2012 Feb; 118(3):620-7. PubMed ID: 21717441
[TBL] [Abstract][Full Text] [Related]
28. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.
Espín F; Bianchi A; Llorca S; Feliu J; Palomera E; García O; Remon J; Suñol X
Eur J Surg Oncol; 2012 Jun; 38(6):497-502. PubMed ID: 22445061
[TBL] [Abstract][Full Text] [Related]
29. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
[TBL] [Abstract][Full Text] [Related]
30. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
[No Abstract] [Full Text] [Related]
31. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy.
Bilici A; Selcukbiricik F; Seker M; Oven BB; Olmez OF; Yildiz O; Olmuscelik O; Hamdard J; Acikgoz O; Cakir A; Kapran Y; Balik E; Oncel M
Oncol Res Treat; 2019; 42(4):209-216. PubMed ID: 30870846
[TBL] [Abstract][Full Text] [Related]
32. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
33. Selective lateral compartment neck dissection for thyroid cancer.
Welch K; McHenry CR
J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
[TBL] [Abstract][Full Text] [Related]
34. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
[TBL] [Abstract][Full Text] [Related]
35. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
[TBL] [Abstract][Full Text] [Related]
36. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
37. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence.
Yip J; Orlov S; Orlov D; Vaisman A; Hernández KG; Etarsky D; Kak I; Parvinnejad N; Freeman JL; Walfish PG
Head Neck; 2013 Apr; 35(4):592-8. PubMed ID: 22730192
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database.
Meng K; Luo H; Chen H; Guo H; Xia W
Medicine (Baltimore); 2019 Jan; 98(1):e13884. PubMed ID: 30608412
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
